Certainly.
Basically two points are made in this letter. The first thing is that, as was mentioned before, it would create a dangerous precedent to legislate on the type and object of research when we have mechanisms that have been set up by Parliament to do this on behalf of the Canadian public and the Canadian government. That's the first thing.
The second thing concerns more specifically CCSVI, which is that we must abide by the principle of clinical research, and get the information, as we're actually proceeding to get it, in a phased fashion.